Xencor, Inc. (XNCR) financial statements (2021 and earlier)

Company profile

Business Address 111 WEST LEMON AVE
MONROVIA, CA 91016
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments603551586574530546505
Cash and cash equivalents1645811074505133
Short-term investments439493477500479495473
Receivables131010822511
Contract with customer, asset13      
Other undisclosed current assets9107672311
Total current assets:638571603588558574527
Noncurrent Assets
Operating lease, right-of-use asset11   9  
Nontrade receivables    000
Property, plant and equipment22201617161412
Long-term investments and receivables1321387274121
Long-term investments1321387274121
Intangible assets, net (including goodwill)16151515141414
Intangible assets, net (excluding goodwill)16151515141414
Other noncurrent assets099901011
Other undisclosed noncurrent assets16      
Total noncurrent assets:66754179112112158
TOTAL ASSETS:703646645667670686685
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities27242018191716
Accounts payable91311101089
Accrued liabilities181197986
Taxes payable     01
Deferred revenue93444546454645
Debt  22222
Other undisclosed current liabilities22     
Total current liabilities:121706666676464
Noncurrent Liabilities
Long-term debt and lease obligation107889910
Operating lease, liability107889910
Liabilities, other than long-term debt    233
Deferred revenue    233
Other undisclosed noncurrent liabilities(10)(7)     
Total noncurrent liabilities: 788101213
Total liabilities:131787474777677
Stockholders' equity
Stockholders' equity attributable to parent572568571593593610608
Common stock1111111
Additional paid in capital938919908896888878865
Accumulated other comprehensive income0111112
Accumulated deficit(366)(352)(339)(304)(296)(269)(259)
Total stockholders' equity:572568571593593610608
TOTAL LIABILITIES AND EQUITY:703646645667670686685

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Gross profit:4235133242219
Operating expenses(56)(52)(51)(41)(34)(36)(39)
Operating loss:(14)(17)(38)(9)(31)(14)(20)
Nonoperating income0431344
Other nonoperating income (expense)(1)30(2)(0)0(0)
Loss from continuing operations before income taxes:(14)(13)(35)(8)(27)(11)(16)
Income tax expense (benefit)    00(0)
Net loss available to common stockholders, diluted:(14)(13)(35)(8)(27)(10)(16)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(14)(13)(35)(8)(27)(10)(16)
Comprehensive loss:(14)(13)(35)(8)(27)(10)(16)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(1)0(0)(0)(0)1
Comprehensive loss, net of tax, attributable to parent:(14)(13)(35)(8)(27)(10)(15)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: